Effects of vardenafil on intraocular pressure and orbital hemodynamics

Journal of Ocular Pharmacology and Therapeutics

Volumn 23, Issue 3, 2007, Pages 275-279

  Taner, Pelin ^a   Murad Basar M ^a   Unal, Birsen ^a   Batislam, Ertan ^a  

^a KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

VARDENAFIL;

ADULT; ARTICLE; BLOOD FLOW; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BRACHIAL PLEXUS; CILIARY ARTERY; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; ERECTILE DYSFUNCTION; EVALUATION; FLUSHING; HEADACHE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEMODYNAMICS; HUMAN; INTRAOCULAR PRESSURE; MALE; OPHTHALMIC ARTERY; ORBIT; RETINA ARTERY; SIDE EFFECT; STATISTICAL SIGNIFICANCE; STUDENT T TEST; SYSTOLE; SYSTOLIC BLOOD PRESSURE;

BLOOD FLOW VELOCITY; BLOOD PRESSURE; CILIARY ARTERIES; HUMANS; IMIDAZOLES; IMPOTENCE; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OPHTHALMIC ARTERY; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; RETINAL ARTERY; SULFONES; TRIAZINES; ULTRASONOGRAPHY, DOPPLER, COLOR; VASODILATOR AGENTS; VISUAL ACUITY;

EID: 34250852794     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2006.121     Document Type: Article

References (28)

1. McCullough, A.R. An update on the PDE5 inhibitors (PDE-5i). J. Androl. 24(Suppl.):S52-S58, 2003.
2. Ückert, S., Küthe, A., Stief, C.G., et al. Phosphodiesterase isoenzymes as pharmacological targets in the treatment of male erectile dysfunction. W. J. Urol. 19:14-22, 2001.
3. Marmor, M.F., and Kessler, R. Sildenafil (Viagra) and ophthalmology. Surv. Opthalmol. 44:153-162, 1999.
4. Pomeranz, H.D., Smith, K.H., Hart, W.M. Jr., et al. Sildenafil-associated nonarteritic anterior ischemic optic neuropathy. Ophthalmology 109:584-587, 2002.
5. Pomeranz, H.D., and Bhavsar, A.R. Nonarteritic ischemic optic neuropathy developing soon after use of sildenafil (Viagra): A report of seven new cases. J. Neuroopthalmol. 25:9-13, 2005.
6. Doggrell, S.A. Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction. Exp. Opin. Pharmacother. 6:75-84, 2005.
7. Rosen, R.C., Catania, J., Pollack, L., et al. Male Sexual Health Questionnaire (MSHQ): Scale development and psychometric validation. Urology 64:777-782, 2004.
8. Williamson, T.H., and Harris, A. Color Doppler ultrasound imaging of the eye and orbit. Surv. Ophthalmol. 40:225-267, 1996.
9. Montorsi, F., Corbin, J., and Phillips, S. Review of phosphodiesterases in the urogenital system: New directions for therapeutic intervention. J. Sex. Med. 1:322-336, 2004.
10. Zusman, R.M., Morales, A., Glasser, D.B., et al. Overall cardiovascular profile of sildenafil citrate. Am. J. Cardiol. 83:35C-44C, 1999.
11. Jackson, G., Benjamin, N., Jackson, N., et al. Effects of sildenafil citrate on human hemodynamics. Am. J. Cardiol. 83:13C-20C, 1999.
12. Thadani, U., Smith, W., Nash, S., et al. The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease. J. Am. Coll. Cardiol. 40:2006-2012, 2002.
13. Reffelmann, T., and Kloner, R.A. Pharmacotherapy of erectile dysfunction: Focus on cardiovascular safety. Exp. Opin. Drug Saf. 4:531-540, 2005.
14. Brindis, R.G., and Kloner, R.A. Sildenafil in patients with cardiovascular disease. Am. J. Cardiol. 92(9A): 26M-36M, 2003.
15. Paris G, Sponsel, W.E., Sandoval, S.S., Chen, N., et al. Sildenafil increases ocular perfusion. Int. Ophthalmol. 23:355-358, 2001.
16. Dundar, S.O., Dundar, M., Koçak, I., et al. Effect of sildenafil on ocular haemodynamics. Eye 15:507-510, 2001.
17. Grunwald, J.E., Siu, K.K., Jacob, S.S., et al. Effect of sildenafil citrate (Viagra) on the ocular circulation. Am. J. Ophthalmol. 133:169-170, 2001.
18. Koksal, M., Ozdemir, H., Kargi, S., et al. The effects of sildenafil on ocular blood flow. Acta. Ophthalmol. (Scand.) 83:355-359, 2005.
19. Dundar, S.O., Dayanir, V., Topaloǧlu, A., et al. Effect of sildenafil on ocular hemodynamics in 3 months regular use. Int. J. Impot. Res. 18:282-286, 2006.
20. Gruhn, N., and Fledelius, H.C. Unilateral optic neuropathy associated with sildenafil intake. Acta. Ophthalmol. (Scand.) 83:31-32, 2005.
21. Egan, R.A., and Fraunfelder, F.W. Arch. Ophthalmol. 123:709-710, 2005.
22. Akash, R., Hirishikesh, D., Amith, P., et al. J. Ocul. Pharmacol. Ther. 21:315-317, 2005.
23. Hattenhauer, M.G., Leavitt, J.A., Hodge, D.O., et al. Incidence of nonarteritic anterior ischemic optic neuropathy. Am. J. Ophthalmol. 123:103-107, 1997.
24. Hayreh, S.S., Podhajsky, P.A., and Zimmerman, B. Nonarteritic ischemic optic neuropathy: time of onset of visual loss. Am. J. Ophthalmol. 124:641-647, 1997.
25. Hatzichiristou, D. Phosphodiesterase 5 inhibitors and nonarteritic anterior ischemic optic neuropathy (NAION): Coincidence or casuality? J. Sex. Med. 6:751-758, 2005.
26. Yajima, T., Yajima, Y., Koppiker, N., et al. No clinically important effects on intraocular pressure after short-term administration of sildenafil-citrate (VIAGRA). Am. J. Ophthalmol. 129:675-676, 2000.
27. Ermis, S.S., Inan, U.U., Samli, M., et al. Acute effects of sildenafil on Humprey visual field and intraocular pressure. Int. Ophthalmol. 25:69-72, 2004.
28. Grunwald, J.E., Jacob, S.S., Siu, K., et al. Acute efffects of sildenafilmcitrate (Viagra®) on intraocular pressure in open-angle glaucoma. Am. J. Ophthalmol. 132: 872-874, 2001.